Partner Headlines - MDCO

  1. Medicines Co. up on sale talk

    IBD
  2. Mid-Afternoon Market Update: Dow Falls Over 400 Points; Advanced ...

    Benzinga
  3. Medicines Company Spikes On Report Of Possible Sale

    IBD
  4. Medicines Co Up For Sale? Bloomberg Info Comes Day After Benzinga ...

    Benzinga
  5. The Medicines Company Announces Investigational Lipid Modulating ...

    Benzinga
  6. Breakaway Gaps By Stocks Can Be Scary But Profitable

    IBD
  7. Benzinga's Top Initiations

    Benzinga
  8. Lilly Kills 'High Risk/High Reward' Cholesterol Drug

    IBD
  9. The Medicines Company Announces BARDA Exercises Next Option on ...

    Benzinga
  10. Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company ...

    Benzinga
  11. Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares ...

    Benzinga
  12. Benzinga's Volume Movers

    Benzinga
  13. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Benzinga's Top Upgrades

    Benzinga
  16. The Medicines Company Announces Participation at 2015 European ...

    Benzinga
  17. Volume And Volatility Alert: Medicines Company

    Benzinga
  18. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD
  19. Medicines Co. gets upgrade

    IBD
  20. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  21. The Medicines Company Announces FDA Approval of KENGREAL as an ...

    Benzinga
  22. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, ...

    GuruFocus
  23. FDA Advisory Committee Recommends Approval of The Medicines Company's ...

    Benzinga
  24. Blood clot preventer gets nod

    IBD
  25. Earnings Scheduled For February 18, 2015

    Benzinga
  26. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD
  27. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  28. Benzinga's Top Upgrades

    Benzinga
  29. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  30. What Investors Should Expect From Rockwell Medical's Next FDA ...

    Benzinga
  31. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  32. Morning Market Losers

    Benzinga
  33. Tuesday's After-Hours Movers

    Benzinga
  34. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  35. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  36. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  37. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  38. Morning Market Movers

    Benzinga
  39. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  40. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  41. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  42. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  43. Benzinga's Top Downgrades

    Benzinga
  44. Benzinga's Top Downgrades

    Benzinga
  45. Medicines Co.

    IBD
  46. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  47. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  48. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  49. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  50. Stocks Hitting 52-Week Lows

    Benzinga
  51. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  52. Morning Market Losers

    Benzinga
  53. Benzinga's Top #PreMarket Losers

    Benzinga
  54. Medicines Co. earnings miss

    IBD
  55. Earnings Scheduled For February 19, 2014

    Benzinga
  56. FDA nixes Medicines' drug

    IBD
  57. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  58. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  59. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  60. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  61. Stocks Hitting 52-Week Lows

    Benzinga
  62. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  63. Benzinga's Top #PreMarket Losers

    Benzinga
  64. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  65. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  66. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  67. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  68. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  69. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  70. Medicines acquires Rempex

    IBD
  71. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  72. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  73. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  74. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  75. A Few Stocks Form Bases, But Have Flaws

    IBD
  76. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  77. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  78. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  79. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  80. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  81. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  82. Medicines Co. In Late Stages Of Base Formation

    IBD
  83. Medicines Co. sales topped

    IBD
  84. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  85. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  86. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  87. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  88. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  89. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  90. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  91. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  92. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  93. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  94. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  95. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  96. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  97. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  98. A Peek Into The Market Before The Trading Starts

    Benzinga
  99. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  100. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
Trading Center